Managing immune checkpoint-blocking antibody side effects

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2015, Pages 76-83

  Postow, Michael A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR; RECOMBINANT PROTEIN; SARGRAMOSTIM;

ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COLITIS; DIARRHEA; DRUG-INDUCED LIVER INJURY; HUMAN; IMMUNOLOGY; OPPORTUNISTIC INFECTIONS;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COLITIS; CTLA-4 ANTIGEN; DIARRHEA; DRUG-INDUCED LIVER INJURY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; OPPORTUNISTIC INFECTIONS; PROGRAMMED CELL DEATH 1 RECEPTOR; RECOMBINANT PROTEINS;

EID: 84969710115     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.14694/EdBook_AM.2015.35.76     Document Type: Review

References (0)